top of page
picture for lab page_edited.jpg

MACIEJ CIEŚLA

Group Leader

Laboratory of Stem Cell RNA Metabolism

Top
Express Interview

SHORT BIO

Dr. Maciej Cieśla has a shared MD and PhD degree from the Jagiellonian University in Poland. For his post-doctoral training with Dr. Cristian Bellodi at Lund Stem Cell Center in Sweden, he studied how splicing factors are controlled at the level of mRNA translation during oncogenic stress. His research focus revolves around understanding of the post-transcriptional gene regulatory networks during cell fate transitions, such as stem cell activation or initial steps of cancerogenesis. In 2021 he joined the ReMedy/IMol PAS to study regulation of splicing in stem cells.

Short Bio

RESEARCH INTERESTS

Laboratory of Stem Cell RNA Metabolism

Our vision is to understand how biology and function of stem cells, indispensable and critical regulators of health, are functionally wired at the level of the metabolism of an evolutionary ancient ribonucleic acid – RNA. We focus on the new facets of the gene expression control, in particular pre-mRNA splicing, an abundant and evolutionary conserved molecular process that boosts the coding capacity of the genome. Our overarching goal is to understand the dynamics of the splicing machinery during discrete developmental cell fate transitions. We anticipate that our research programme will provide novel insights relevant not only for a basic stem cell biology, but also for establishment of molecular associations in pathologies related to a stem cell dysfunction, including tissue failure and cancer.

Research Interest

FUNDING

2019

  • postdoctoral research grant from Swedish Cancer Foundation (Cancerfonden).

  • postdoctoral research grant from Swedish Foundation for Medical Research (SSMF). Gratefully declined.

 

2013

  • New model in research on rhabdomyosarcoma development: role of heme oxygenase-1 in rhabdomyosarcoma pathology, Foundation for Polish Science, Ventures program 2013- 11/2.

  • Long-lasting effects of small-molecule inhibitors of heme oxygenase-1 in rhabdomyosarcoma development, grant from the founds of Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University.

  • stipend from Ministry of Higher Education for the best PhD students.

 

2012

  • Influence of small-molecule inhibitors of heme oxygenase-1 on rhabdomyosarcoma development in in vivo animal model, grant from the founds of Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University.

2011

  • New strategy for rhabdomyosarcoma treatment: induction of tumor differentiation, Foundation for Polish Science, Ventures program 2011- 7/2.

  • stipends from structural founds of Jagiellonian University, awarded yearly based on the merit.

2010

  • Medical Research Council UK Fellowship for Internship at Laboratory of Molecular Biology of Cambridge University.

2006

  • Erasmus-Mundus stipendship

Funding

PUBLICATIONS 

2022

  • Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukemic progression in myelodysplastic syndrome, Guzzi N#, Muthukumar S#, Cieśla M#, Todisco G, Ngoc PCT, Madej M, Munita R, Fazio S, Ekström S, Mortera-Blanco T, Jansson M, Nannya Y, Cazzola M, Ogawa S, Malcovati L, Hellström-Lindberg E, Dimitriou M*, Bellodi C, Nature Cell Biology 2022 in press.

 

2021

  • The small Cajal body-specific RNA 15 (SCARNA15) directs p53 and redox homeostasis via selective splicing in cancer cells, Beneventi G, Munita R, Cao Thi Ngoc P, Madej M, Cieśla M, Muthukumar S, Krogh N, Nielsen H, Swaminathan V, Bellodi C, NAR Cancer. 2021 Jul 9;3(3):zcab026. doi: 10.1093/narcan/zcab026. eCollection 2021 Sep.

  • Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer, Cieśla M, Ngoc PCT, Cordero E, Martinez AS, Morsing M, Muthukumar S, Beneventi G, Madej M, Munita R, Jönsson T, Lövgren K, Ebbesson A, Nodin B, Hedenfalk I, Jirström K, Vallon-Christersson J, Honeth G, Staaf J, Incarnato D, Pietras K, Bosch A, Bellodi C., Mol Cell, in press.

 

2020

  • Lack of miR-378 attenuates muscular dystrophy in mdx mice. Podkalicka P, Mucha O, Bronisz-Budzyńska I, Kozakowska M, Pietraszek-Gremplewicz K, Cetnarowska A, Głowniak-Kwitek U, Bukowska-Strakova K, Cieśla M, Kulecka M, Ostrowski J, Mikuła M, Potulska-Chromik A, Kostera-Pruszczyk A, Józkowicz A, Łoboda A, Dulak J. JCI Insight. 2020 Jun 4;5(11):e135576.

  • RNA in Cancer, Ciesla M, Chapter 11 in Rna-Based Regulation in Human Health and Disease (Elsevier), Volume 19 in Translational Epigenetics.

  • Electron paramagnetic resonance spectroscopy reveals alterations in the redox state of endogenous copper and iron complexes in photodynamic stress-induced ischemic mouse liver. Jakubowska MA, Pyka J, Michalczyk-Wetula D, Baczyński K, Cieśla M, Susz A, Ferdek PE, Płonka BK, Fiedor L, Płonka PM. Redox Biol. 2020 Jul;34:101566.

  • Heme oxygenase-1 deficiency triggers exhaustion of hematopoietic stem cells. Szade K, Zukowska M, Szade A, Nowak W, Skulimowska I, Ciesla M, Bukowska-Strakova K, Gulati GS, Kachamakova-Trojanowska N, Kusienicka A, Einwallner E, Kijowski J, Czauderna S, Esterbauer H, Benes V, L Weissman I, Dulak J, Jozkowicz A. EMBO Rep. 2020 Feb 5;21(2):e47895.

 

2019

  • Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood. Szade A, Szade K, Nowak WN, Bukowska-Strakova K, Muchova L, Gońka M, Żukowska M, Cieśla M, Kachamakova-Trojanowska N, Rams-Baron M, Ratuszna A, Dulak J, Józkowicz A. EMBO Mol Med. 2019 Dec;11(12):e09571.

  • The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma, Phung B, Cieśla M, Sanna A, Guzzi N, Beneventi G, Ngoc PCT, Lauss M, Cabrita R, Cordero E, Bosch A, Rosengren F, Häkkinen J, Griewank K, Paschen A, Harbst K, Olsson H, Ingvar C, Carneiro A, Tsao H, Schadendorf D, Pietras K, Bellodi C, Jönsson G, Cell Rep;27(12):3573-3586.e7. Joint first authorship.

 

2018

  • Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice. Pietraszek-Gremplewicz K, Kozakowska M, Bronisz-Budzynska I, Ciesla M, Mucha O, Podkalicka P, Madej M, Glowniak U, Szade K, Stepniewski J, Jez M, Andrysiak K, Bukowska-Strakova K, Kaminska A, Kostera-Pruszczyk A, Jozkowicz A, Loboda A, Dulak J. Antioxid Redox Signal. 2018 Jul 10;29(2):128-148.

  • Pseudouridylation of tRNA-Derived Fragments Steers Translational Control in Stem Cells, Guzzi N, Cieśla M, Ngoc PCT, Lang S, Arora S, Dimitriou M, Pimková K, Sommarin MNE, Munita R, Lubas M, Lim Y, Okuyama K, Soneji S, Karlsson G, Hansson J, Jönsson G, Lund AH, Sigvardsson M, Hellström-Lindberg E, Hsieh AC, Bellodi C. Cell;173(5):1204–1216.

  • Heme oxygenase-1 affects generation and spontaneous cardiac differentiation of induced pluripotent stem cells, Stepniewski J, Pacholczak T, Skrzypczyk A, Ciesla M, Szade A, Szade K, Bidanel R, Langrzyk A, Grochowski R, Vandermeeren F,  Kachamakova-Trojanowska N,  Jez M, Drabik G,  Nakanishi M,  Jozkowicz A, Dulak J, IUBMB Life. 2018 Jan 9.

 

2017

  • Lack of Heme Oxygenase-1 Induces Inflammatory Reaction and Proliferation of Muscle Satellite Cells after Cardiotoxin-Induced Skeletal Muscle Injury, Kozakowska M, Pietraszek-Gremplewicz K, Ciesla M, Seczynska M, Bronisz-Budzynska I, Podkalicka P, Bukowska-Strakova K, Loboda A, Jozkowicz A, Dulak J, Am J Pathol. 2017 Nov 21. pii: S0002-9440(17)30471-6.

  • Valproic acid downregulates heme oxygenase-1 independently of Nrf2 by increasing ubiquitination and proteasomal degradation, Jez M, Ciesla M, Stepniewski J, Langrzyk A, Muchova L, Vitek L, Jozkowicz A, Dulak J, Biochem Biophys Res Commun, 2017 Mar 25;485(1):160-166.

 

2016

  • Heme oxygenase 1 affects granulopoiesis in mice through control of myelocyte proliferation. Bukowska-Strakova K, Ciesla M, Szade K, Nowak W, Straka R, Szade A, Tyszka-Czochara M, Najder K, Konturek A, Siedlar M, Dulak J, Jozkowicz A. Immunobiology 2016.

  • Heme Oxygenase-1 Controls an HDAC4-miR-206 Pathway of Oxidative Stress in Rhabdomyosarcoma, Ciesla M, Marona P, Kozakowska M, Jez M, Seczynska M, Loboda A, Bukowska-Strakova K, Szade A, Walawender M, Kusior M, Stepniewski J, Szade K, Krist B, Yagensky O, Urbanik A, Kazanowska B, Dulak J, Jozkowicz A. Cancer Res. 2016 Oct 1;76(19):5707-5718.

 

2015

  • Association of Calcium and Phosphate Balance, Vitamin D, PTH, and Calcitonin in Patients with Adolescent Idiopathic Scoliosis, Goździalska A, Jaśkiewicz J, Knapik-Czajka M, Drąg J, Gawlik M, Cieśla M, Kulis A, Zarzycki D, Lipik E. Spine (Phila Pa 1976). 2016 Apr;41(8):693-7.

  • Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice. Kozakowska M, Kotlinowski J, Grochot-Przeczek A, Ciesla M, Pilecki B, Derlacz R, Dulak J, Jozkowicz A, Stem Cell Res Ther. 2015 Apr 12; 6:61. 

 

2014

  • MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development, Cieśla M, Dulak J, Józkowicz A, Int J Biochem Cell Biol. 2014 Aug;53:482-92.

 

2013

  • Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis, Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H, Gil T, Kuzdzal J, Muchova L, Vitek L, Loboda A, Jozkowicz A, Kieda C, Dulak J, Antioxid Redox Signal. 2013 Sep 1;19(7):644-60.

  • Development of hyperglycemia and diabetes in captive Polish bank voles, Bartelik A, Ciesla M, Kotlinowski J, Bartelik S, Czaplicki D, Grochot-Przeczek A, Kurowski K, Koteja P, Dulak J, Józkowicz A, Gen Comp Endocrinol. 2013 Mar 1. Joint first authorship.

  • Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells, Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, Jozkowicz A, Dulak J, Loboda A, Mol Nutr Food Res. 2013 Mar.

 

2012

  • Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs, Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, Jozkowicz A, Antioxid Redox Signal. 2012 January 15. Joint first authorship.

 

2011

  • microRNAs as biomarkers of disease onset, Ciesla M, Skrzypek K, Kozakowska M, Łoboda A, Józkowicz A, Dulak J, Anal Bioanal Chem., 2011 May 6.

  • Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington’s disease, Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Björkqvist M., Hum Mol Genet. 2011 April 1. Joint first authorship.

  • Stage-Specific Modulation of Cortical Neuronal Development by Mmu-miR-134, Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P. Cereb Cortex. 2011 January 12.

CONTACT

Publications
Contact
bottom of page